R
Redcliffe Labs
Dedicated Genetics and Genomics research company based out of Sec-63 Noida
About Redcliffe Labs
Redcliffe Labs operates as an omnichannel diagnostics service provider in India, founded in 2018 by Dheeraj Jain, Ashish Dubey, and Aditya Kandoi. The company was established to address the gap in accessible and affordable high-quality diagnostic services, particularly in India's smaller cities and underserved regions. Dheeraj Jain, a serial entrepreneur and angel investor with extensive experience in corporate strategy, co-founded several other ventures, including PeeSafe and Crysta IVF. The founders' collective experience in healthcare, technology, and early-stage investments shaped the company's direction. Aditya Kandoi currently serves as the CEO, with Dheeraj Jain as the Chairman of the Board.
The company's business model combines a digital-first approach with a physical network of laboratories and collection centers. Revenue is primarily generated from a comprehensive portfolio of over 3,600 diagnostic tests, ranging from routine pathology to advanced genetic screening for reproductive health, cancer, and wellness. In the fiscal year 2025, the company reported revenue of ₹419 crore, with diagnostic services accounting for over 95% of this total. Redcliffe Labs serves individuals, healthcare providers, and corporate clients, with a strategic focus on expanding its reach in Tier II and III cities, which now account for over 70% of its diagnostic volumes.
Redcliffe Labs offers a platform that enables users to book diagnostic tests online, with the convenience of at-home sample collection and same-day reporting. The service is underpinned by a network of more than 80 laboratories and over 2,000 collection centers across more than 220 cities in India. A key operational feature is the use of technology to enhance efficiency, including being a pioneer in using drones for medical sample transport. The company provides easy-to-interpret smart reports to help with timely diagnosis and treatment. To make its services widely available, Redcliffe utilizes a franchise model for its collection centers and offers various health packages and promotional discounts.
The company has achieved significant financial milestones, securing a total of $116 million in funding across several rounds. A notable Series C round in September 2024 raised $42 million, led by Denmark's Investment Fund for Developing Countries (IFU), to fuel further expansion into smaller cities. Strategic acquisitions, such as the purchase of Celara Diagnostics, are also part of its growth strategy. While the company has seen substantial revenue growth, it also reported increased losses in FY23 before significantly narrowing them in FY24 and FY25, reducing EBITDA losses from -38% to -21% in the last fiscal year.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 146
- Open positions
- None listed
- Dealroom signal
- 56.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company, latest Sep 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Sep 2024 | $42M | $305M | HealthQuad · Investment Fund for Developing Countries · LeapFrog Investments · Spark Growth Ventures | ↗ |
| SERIES BOther financing | May 2022 | $61M | $244M | Schroders · HealthQuad · LeapFrog Investments · Chiratae Ventures | ↗ |
Growth signals
Latest recorded traffic for Redcliffe Labs is 740 monthly website visits, up 13.8% over the last three months. Redcliffe Labs's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Redcliffe Labs in the Noida ecosystem
The Redcliffe Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Asymmetry Ventures
Series A7 investors entered at this stage
Spark Growth Ventures
LeapFrog Investments
Schroders
HealthQuad
Chiratae Ventures
Alkemi Growth Capital- LALC Nueva AIF
Series B and later1 investor entered at this stage
Investment Fund for Developing Countries
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Redcliffe Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Redcliffe Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










